Endocrinologic and Metabolic Drugs
Advisory Committee
September 9, 2005

Table of Contents:

1. Preclinical Pharmacology and Toxicology Summary

2. Medical Officer Evaluation of Efficacy

3. Medical Officer Evaluation of Safety

4. Background and Summary of Issues (Division Director)

5. Draft Questions for Discussion

6. Addendum - Statistical Review and Evaluation

7. Errata Sheet